Shares of Sana Biotechnology (NASDAQ:SANA) rallied 270% post-market on positive results from a study of the transplantation ...

(RTTNews) - Immuneering Corp. (IMRX), Tuesday announced positive data update from three arms of its ongoing Phase 2a trial of lead program IMM-1-104 for the treatment of patients with Pancreatic ...

(Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced ...

This discovery points to a new way to tackle pancreatic cancer. If scientists can find a way to block CD9 or stop the cancer ...

INR:5012. under-15 cricket world cup winners list Micro Hotspot丨More than 5,000 patients take veterinary drugs to fight cancer? They are ...

In February 2024, the FDA approved Onivyde (irinotecan liposome) with oxaliplatin, fluorouracil and leucovorin for the ...

The quip, which came after a member of the public asked Charles how he was, followed reports on Friday that the 76-year-old sovereign will continue his cancer treatment into next year. Buckingham ...

“It’s like each tissue leaves its address on a tag in case its cells end up in the lost and found.” The team found different sets of fingerprints in diseased tissue samples from patients with cancer, ...

FRANKFURT. Various forms of blood cancer exist – all of which are grouped together under the term leukemia. One common form of leukemia is acute myeloid leukemia (AML), characterized by a degradation ...

It was a chance to show Moss that the Vikings past, present, and future are behind him every step of the way as he continues his fight against cancer. “We just wanted to do whatever we could ...

This FDA approval of the first NRG1 fusion-targeted therapy in pancreatic (as well as in non-small cell lung) cancer marks a pivotal moment for precision medicine in drug development and pancreatic ...